期刊文献+

Exendin-4类似物对糖尿病大鼠视网膜电图的保护作用 被引量:2

Protection of exendin-4 analog on ERG and Ops in experimental diabetic rats
下载PDF
导出
摘要 目的:观察exendin-4类似物ip对链脲佐菌素(STZ)造模大鼠的血糖和ERG的影响。方法:SD大鼠36只被分成3组:正常组8只、糖尿病每日ip注射生理盐水组8只和exendin-4类似物0.05μg/g治疗组20只。检测exendin-4类似物注射期间血糖水平,糖尿病病程1mo和3mo时ERG和OPs的表现。结果:STZ造模大鼠连续exendin-4类似物注射期间平均血糖和正常组差异无统计学意义(P>0.05);而与注射用水组比较血糖明显降低(P<0.05);糖尿病大鼠ERG的b波、OPs振幅随病程进展有下降趋势,且潜伏期延长;ex-endin-4类似物治疗组的下降幅度明显小于注射用水组,统计学有差异(P<0.05)。结论:Exendin-4类似物对STZ造模大鼠有降低血糖的作用,而且可改善糖尿病大鼠ERG表现。 AIM : To observe the effect of exendin-4 analog on blood glucose in diabetic rats induced by streptozotocin (STZ) and the influence on their electroretinogram (ERG). METHODS: Thirty-six rats were included in the experiment. The rats were divided into 3 groups: normal control (N, n=8), diabetic control (D, n=8) and E4atreated group (E4a, n = 20). For E4a group, the rats were treated with E4a S.C. (0.05ug/g BW/d). For N and D groups, the rats were treated with normal saline (NS). S.C. Blood glucose levels and body weight was measured weekly. ERGs were recorded 1 and 3 months after injection. RESULTS: The difference of blood glucose in diabetic rats between the groups with E4a treated and the normal control was of no significance (6.68 ± 0.37 vs 6.95 ± 0.41mmol/L, P〉 0.05). The blood glucose of E4a group was much lower than that of D group. The amplitude of b-wave and oscillatory potentials (OPs) showed decrease with the progress of diabetes. The decrease in E4a treated group was less than that in untreated ones and had statistical significance ( P 〈 0.05). CONCLUSION: E4a can normalize the blood glucose of diabetic rats. Diabetes leads to the progressive decreases in the amplitudes of b-wave and OPs. E4a can reverse them nearly to their normal condition.
出处 《国际眼科杂志》 CAS 2008年第8期1573-1575,共3页 International Eye Science
关键词 高血糖 视网膜电图 视网膜病变 exendin-4类假物 high glucose diabetic retinopathy exendin-4 analog electroretinogram
  • 引文网络
  • 相关文献

参考文献9

  • 1Nathan DM,Schreiber E,Fogel H, et al. Insulinotropic action of glucagonlike peptide-1-(7-37)in diabetic and nondiabetic subjects.Diabetes Care 1992 ; 15 : 270-276
  • 2Eng J, Kleinman WA, Singh L, et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom, Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.J Biol Chem 1992 ;267:7402-7405
  • 3Szayna M, Doyle ME, Betkey JA, et al. Exendin-4 decelerates food intake, weight gain and fat deposition in Zucker rats. Endocrinology 2000;141:1936-1941
  • 4De Leon DD, Deng S, Madani R, et al. Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 2003 ;52:365-371
  • 5Wang Q, Brubuker PL. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week old db/db mice.Diabetologia 2002;45:1263- 1273
  • 6Papakostopoulos D, Hart JC, Corrall RJ, et al. The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent diabetes. Int J Psychophysiol 1996 ;21 ( 1 ) :33-43
  • 7Wurziger K, Lichtenberger T, Hanitzsch R. On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vis Res 2001 ;41:1091-1101
  • 8罗仁南,张富文,段俊国,刘冀.糖尿病早期大鼠视网膜功能的多焦视网膜电图研究[J].国际眼科杂志,2007,7(6):1558-1562. 被引量:1
  • 9Bresnick GH, Korth K, Groo A, et al. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 1984;102(9) :1307-1311

二级参考文献5

同被引文献34

  • 1张蕾,周舟,张广斌,余争平.微波暴露对大鼠GLP-1及其受体表达的影响及与学习记忆功能损伤的关系[J].辐射研究与辐射工艺学报,2007,25(3):180-184. 被引量:1
  • 2Yue FM,Cui L.Glucagon-like peptide-1differentiation of primate embryonic stem cells into insulin producing.Cells Tissue Engineering,2006,12(8):2105-2116.
  • 3Suzuki A,Nakauchi H,Taniguchi H.Glucagon-like peptide 1(1-37) converts intestinal epithelial cells into insulin-producing cells.PNAS,2003,100(9):5034-5039.
  • 4Meier JJ,Gallwitz B,Schmidt WE,et al.Glucagon-like peptide 1 as a regulator of food intake and body weight:therapeutic perspectives.Eur J Pharmacol,2002,440(2-3):269-279.
  • 5Schick RR,Zimmermann JP,Vorm WT,et al.Glucagon-like-peptide (GLP)-1 (7-36) amide:a central suppressor of food intake in fasted rats.Gastroenterology,1992,102:A750.
  • 6Young AA,Gendulin BR,Bhavsar S,et al.Glucose-lowering and insulin-sensitizing acitons of exendin-4:studies in obese diabetic(ob/ob,db/db)mice,diabetic fatty Zucker rats,and diabetic rhesus monkeys (Macaca mulatta).Diabetes,1999,48(5):1026-1034.
  • 7Perry T,Lahiri DK,Chen D,et al.A novel neurotrophic property of glucagon-like peptide 1:a promoter of nerve growth factor-mediated differentiation in PC12 cells.J Pharmacol Exp Ther,2002,300(3):958-966.
  • 8Alvarez E,Roncero I,Chowen JA,et al.Expression of the glucagon-like peptide-1 receptor gene in rat brain.J Neurochem,1996,66(3):920-927.
  • 9Li Y,Perry T,Kindy M,et al.GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and parkinsonism.PNAS,2009,106(4):1285-1290.
  • 10Nikolaidis LA,Mankad S,Sokos GG,et al.Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.Circulation,2004,109(8):962-965.

引证文献2

二级引证文献5

相关主题

;
使用帮助 返回顶部